Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping
Papaxoinis, George, Kotoula, Vassiliki, Giannoulatou, Eleni, Koliou, Georgia-Angeliki, Karavasilis, Vasilios, Lakis, Sotirios, Koureas, Andreas, Bobos, Mattheos, Chalaralambous, Elpida, Daskalaki, EmiVolume:
35
Language:
english
Journal:
Medical Oncology
DOI:
10.1007/s12032-018-1160-1
Date:
July, 2018
File:
PDF, 1.22 MB
english, 2018